Cytogel Pharma Stock
Cytogel Pharma is a bio-pharmaceutical development company that pursues strategic opportunities for pharmaceutical product development.
About Cytogel Pharma Stock
Cytogel Pharma (Cytogel) is a bio-pharmaceutical development company founded in 2002 to pursue strategic opportunities for pharmaceutical product development. The company focuses on acquiring promising early-stage programs that offer significant potential both as platform technologies and high value product candidates. Milestone-defined investment of corporate resources permits the company to enhance product value for partnering or licensing, while retaining optimal equity value for our investors. Cytogel is venture backed by Centripetal Capital Partners.
C. Dean Maglaris
Licensing and Business Development
James J. Hamsher
Chief Scientific Officer/cofounder & Director